Yuliia A. Fedchenkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuliia A. Fedchenkova has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Sergii Demchenko
Department of Chemistry, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, RJ, Brazil
8 shared publications - Kateryna Skrebtsova
National University of Pharmacy
6 shared publications - Olga P. Khvorost
National University of Pharmacy
6 shared publications - Irina Yu. Posokhova
Національний фармацевтичний університет Міністерства охорони здоров’я України
3 shared publications - Hanna Yeromina
National University of Pharmacy
2 shared publications - Ludmila Bobkova
ДУ«Інститут фармакології та токсикології НАМН України», Київ, Україна
2 shared publications
Latest Publications
- 30 September 2026
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 22, 1-18
Triazin-5-ones Derivatives as Potential Antiseizure Medicines
Introduction: Epilepsy is a major global health burden, affecting more than 70 million people worldwide. Approximately 20-30% of patients do not achieve adequate seizure control with currently available antiseizure medications. This study investigates novel triazin-5-one derivatives as potential antiseizure agents targeting the γ-aminobutyric acid (GABA) system. The compounds were designed to interact with GABAA receptors and inhibit GABA aminotransferase (GABA-AT), using lamotrigine as a reference antiseizure drug. This dual-target strategy may support the development of more effective therapies for drug-resistant epilepsy. Materials and Methods: Eighteen 6-(4-methoxybenzyl)-3-R-4H-[1,2,4]triazin-5-one derivatives (3a–r) were synthesized and characterized by 1H and 13C NMR spectroscopy, LC-MS, and elemental analysis. Molecular docking was performed against the GABAA receptor (PDB ID: 1OHV) and GABA-AT enzyme (PDB ID: 1SF2) to estimate binding affinity. GABA-AT inhibition was evaluated in vitro, and anticonvulsant activity was assessed in mouse models at doses equimolar to 10 mg/kg lamotrigine. Results: Compounds 3o, 3f, 3r, 3g, and 3h showed the highest predicted binding affinities for the GABAA receptor, with binding-energy magnitudes exceeding 10 kcal/mol. Compound 3h (3-(2,3-dimethylphenylamino)-6-(4-methoxybenzyl)-4H-[1,2,4]triazin-5-one) exhibited the lowest IC50 value for GABA-AT inhibition (30.50 ± 0.61 μM), comparable to that of lamotrigine (32.7 ± 0.7 μM). In the animal model, compounds 3f and 3h completely suppressed clonic and recurrent clonic-tonic seizures. Docking analysis indicated that 3h forms hydrogen bonds with Arg430 and Ile426 through the triazine oxygen atom and interacts with His44 through a triazine nitrogen atom. Discussion: The anticonvulsant effects of these 1,2,4-triazine derivatives appear to depend on the substituents at positions 3 and 6 of the heterocyclic ring. Their potential dual mechanism, involving both receptor modulation and enzyme inhibition, may contribute to their neurotropic activity. Compound 3r contains a defined pharmacophore incorporating tryptamine and triazine fragments, whereas the spatial requirements underlying the activity of compound 3h remain unclear and require further structural investigation. Conclusion: The study identifies novel triazin-5-ones, specifically compounds 3h and 3f, as promising candidates for the development of new antiseizure therapies. These derivatives demonstrate potency and efficacy comparable to lamotrigine and may offer a multi-target mechanism within the GABAergic system.
- 30 September 2026
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 22, 1-18
Triazin-5-ones Derivatives as Potential Antiseizure Medicines
Introduction: Epilepsy is a major global health burden, affecting more than 70 million people worldwide. Approximately 20-30% of patients do not achieve adequate seizure control with currently available antiseizure medications. This study investigates novel triazin-5-one derivatives as potential antiseizure agents targeting the γ-aminobutyric acid (GABA) system. The compounds were designed to interact with GABAA receptors and inhibit GABA aminotransferase (GABA-AT), using lamotrigine as a reference antiseizure drug. This dual-target strategy may support the development of more effective therapies for drug-resistant epilepsy. Materials and Methods: Eighteen 6-(4-methoxybenzyl)-3-R-4H-[1,2,4]triazin-5-one derivatives (3a–r) were synthesized and characterized by 1H and 13C NMR spectroscopy, LC-MS, and elemental analysis. Molecular docking was performed against the GABAA receptor (PDB ID: 1OHV) and GABA-AT enzyme (PDB ID: 1SF2) to estimate binding affinity. GABA-AT inhibition was evaluated in vitro, and anticonvulsant activity was assessed in mouse models at doses equimolar to 10 mg/kg lamotrigine. Results: Compounds 3o, 3f, 3r, 3g, and 3h showed the highest predicted binding affinities for the GABAA receptor, with binding-energy magnitudes exceeding 10 kcal/mol. Compound 3h (3-(2,3-dimethylphenylamino)-6-(4-methoxybenzyl)-4H-[1,2,4]triazin-5-one) exhibited the lowest IC50 value for GABA-AT inhibition (30.50 ± 0.61 μM), comparable to that of lamotrigine (32.7 ± 0.7 μM). In the animal model, compounds 3f and 3h completely suppressed clonic and recurrent clonic-tonic seizures. Docking analysis indicated that 3h forms hydrogen bonds with Arg430 and Ile426 through the triazine oxygen atom and interacts with His44 through a triazine nitrogen atom. Discussion: The anticonvulsant effects of these 1,2,4-triazine derivatives appear to depend on the substituents at positions 3 and 6 of the heterocyclic ring. Their potential dual mechanism, involving both receptor modulation and enzyme inhibition, may contribute to their neurotropic activity. Compound 3r contains a defined pharmacophore incorporating tryptamine and triazine fragments, whereas the spatial requirements underlying the activity of compound 3h remain unclear and require further structural investigation. Conclusion: The study identifies novel triazin-5-ones, specifically compounds 3h and 3f, as promising candidates for the development of new antiseizure therapies. These derivatives demonstrate potency and efficacy comparable to lamotrigine and may offer a multi-target mechanism within the GABAergic system.
- Open Access
- 26 May 2025
- Published by National University of Pharmacy in Social Pharmacy in Health Care
- Vol. 11 (1) , 80-92
Prospects for expanding the range of medicinal products based on velvet antlers
Reindeer antlers (maral, bison, spotted deer) have long been used in folk and official medicine in the world. Despite a significant number of studies of antlers as sources of biologically active substances (BAS), the study of their synergistic properties and diverse current aspects of application, the range of the raw material and products in the pharmaceutical market of Ukraine requires a more detailed study. Aim. To determine the feasibility of creating new medicines from antler BAS by analyzing the range of the medicinal raw material, medicines, dietary supplements and other pharmacy products based on antlers in the pharmaceutical market of Ukraine. Materials and methods. The analysis of the range of medicines and dietary supplements was carried out based on data from the State Register of Medicines of Ukraine, the electronic resource Compendium.online, according to the ATC classification system as of January – February, 2025. Information on retail prices was obtained from the online service www.tabletki.ua and available online marketplaces. The methods of information and bibliographic search, systematization, analysis and generalization, comparative, marketing, content analysis and graphic were used in the work. Results. Based on the results of the study, it was determined that only one product name with the antler raw material was registered as a medicinal product – “Pantocrin”, liquid extract, 50 ml, manufactured by Ternopharm (Ukraine). Among the entire product range, the share of dietary supplements is almost 93 %. The main suppliers of these products are foreign manufacturers from China and the USA, which total share is 63.6 %, domestic manufacturers account for 25 % of the range. It has been found that the domestic pharmaceutical market contains the raw material of antlers (slices, powder), dry and liquid extracts, liquid dosage forms (tinctures, drops, elixirs), tablets, pills, capsules, creams, cream-balms, gels, sprays and teas. Conclusions. The results obtained have shown the prospects of developing new domestic complex and combined medicines, which include BAS of antlers. However, it is necessary to take into account possible contraindications to their use.
- 26 May 2025
- Published by National University of Pharmacy in Social Pharmacy in Health Care
- Vol. 11 (1) , 80-92
Open AccessProspects for expanding the range of medicinal products based on velvet antlers
Reindeer antlers (maral, bison, spotted deer) have long been used in folk and official medicine in the world. Despite a significant number of studies of antlers as sources of biologically active substances (BAS), the study of their synergistic properties and diverse current aspects of application, the range of the raw material and products in the pharmaceutical market of Ukraine requires a more detailed study. Aim. To determine the feasibility of creating new medicines from antler BAS by analyzing the range of the medicinal raw material, medicines, dietary supplements and other pharmacy products based on antlers in the pharmaceutical market of Ukraine. Materials and methods. The analysis of the range of medicines and dietary supplements was carried out based on data from the State Register of Medicines of Ukraine, the electronic resource Compendium.online, according to the ATC classification system as of January – February, 2025. Information on retail prices was obtained from the online service www.tabletki.ua and available online marketplaces. The methods of information and bibliographic search, systematization, analysis and generalization, comparative, marketing, content analysis and graphic were used in the work. Results. Based on the results of the study, it was determined that only one product name with the antler raw material was registered as a medicinal product – “Pantocrin”, liquid extract, 50 ml, manufactured by Ternopharm (Ukraine). Among the entire product range, the share of dietary supplements is almost 93 %. The main suppliers of these products are foreign manufacturers from China and the USA, which total share is 63.6 %, domestic manufacturers account for 25 % of the range. It has been found that the domestic pharmaceutical market contains the raw material of antlers (slices, powder), dry and liquid extracts, liquid dosage forms (tinctures, drops, elixirs), tablets, pills, capsules, creams, cream-balms, gels, sprays and teas. Conclusions. The results obtained have shown the prospects of developing new domestic complex and combined medicines, which include BAS of antlers. However, it is necessary to take into account possible contraindications to their use.
- 1 January 2024
- Published by Publishing House Helvetica (Publications) in Fitoterapia
- No. 3,p. 200-206
Component composition and quantitative content of organic acids in rhizomes with roots of Rumex confertus Willd
- 1 January 2024
- Published by Publishing House Helvetica (Publications) in Fitoterapia
- No. 3,p. 200-206
Component composition and quantitative content of organic acids in rhizomes with roots of Rumex confertus Willd
- Open Access
- 25 May 2022
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 20 (1(77)) , 57-62
The quantitative content determination of main groups of biologically active substances in batches of Viburnum opulus fruits
Aim. To determine the quantitative content of the main groups of biologically active substances (BAS) in batches of Viburnum opulus fruits using pharmacopeial methods for their subsequent use in the standardization of the plant raw material.Materials and methods. For the study, 6 batches of air-dried Viburnum opulus fruits crushed to a particle size of 1 – 2 mm and harvested in different regions of Ukraine in the mass fruiting phase in October-November 2020 were used. The quantitative determination of polyphenols and tannins was performed using the spectrophotometric method at a wavelength of 760 nm calculated with reference to pyrogallol and dried substance. The total amount of hydroxycinnamic acids was determined according to the method of the SPhU (State Pharmacopoeia of Ukraine) 2.0 described in the monograph “Kidney TeaN” calculated with reference to rosemary acid. The total amount of organic acids was determined by the titrimetric method according to the method of the monograph of the SPhU 2.1 “Rose hipsN” calculated with reference to malic acid.Results and discussion. The quantitative content of polyphenols (calculated with reference to pyrogallol and dried substance) in batches of Viburnum opulus fruits varied by about 1.4 times from 1.74 ± 0.01 % to 2.36 ± 0.01 %. According to the results obtained, the quantitative content of tannins (calculated with reference to pyrogallol and dried substance) in batches of Viburnum opulus fruits varied by 1.7 times from 0.73 ± 0.01 % to 1.23 ± 0.01 %. The quantitative content of the total amount of hydroxycinnamic acids calculated with reference to rosemary acid in batches of Viburnum opulus fruits ranged by 1.2 times from 3.96 ± 0.01 % to 4.73 ± 0.01 %. The quantitative content of the total amount of organic acids calculated with reference to malic acid in batches of Viburnum opulus fruits fluctuated more than 1.3 times from 6.80 ± 0.01 % to 9.08 ± 0.01 %.Conclusions. The quantitative content of the main groups of biologically active substances has been determined in 6 batches of Viburnum opulus fruits harvested in different regions of Ukraine using pharmacopoeial methods: polyphenols (varied by 1.4 times), tannins (varied by 1.7 times), the total amount of hydroxycinnamic (varied by 1.2 times), and the total amount of organic acids (varied by 1.3 times) calculated with reference to dried substance. The content of the groups of biologically active substances in batches of Viburnum opulus fruits slightly correlates with the place of the raw material harvesting. Thus, the selected methods of the SPhU 2.0 are quite suitable for determining the quantitative content of polyphenols, tannins and of the total amount of hydroxycinnamic and organic acids in batches of Viburnum opulus fruits; they can be used in further studies to standardize the raw material.
- 25 May 2022
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 20 (1(77)) , 57-62
Open AccessThe quantitative content determination of main groups of biologically active substances in batches of Viburnum opulus fruits
Aim. To determine the quantitative content of the main groups of biologically active substances (BAS) in batches of Viburnum opulus fruits using pharmacopeial methods for their subsequent use in the standardization of the plant raw material.Materials and methods. For the study, 6 batches of air-dried Viburnum opulus fruits crushed to a particle size of 1 – 2 mm and harvested in different regions of Ukraine in the mass fruiting phase in October-November 2020 were used. The quantitative determination of polyphenols and tannins was performed using the spectrophotometric method at a wavelength of 760 nm calculated with reference to pyrogallol and dried substance. The total amount of hydroxycinnamic acids was determined according to the method of the SPhU (State Pharmacopoeia of Ukraine) 2.0 described in the monograph “Kidney TeaN” calculated with reference to rosemary acid. The total amount of organic acids was determined by the titrimetric method according to the method of the monograph of the SPhU 2.1 “Rose hipsN” calculated with reference to malic acid.Results and discussion. The quantitative content of polyphenols (calculated with reference to pyrogallol and dried substance) in batches of Viburnum opulus fruits varied by about 1.4 times from 1.74 ± 0.01 % to 2.36 ± 0.01 %. According to the results obtained, the quantitative content of tannins (calculated with reference to pyrogallol and dried substance) in batches of Viburnum opulus fruits varied by 1.7 times from 0.73 ± 0.01 % to 1.23 ± 0.01 %. The quantitative content of the total amount of hydroxycinnamic acids calculated with reference to rosemary acid in batches of Viburnum opulus fruits ranged by 1.2 times from 3.96 ± 0.01 % to 4.73 ± 0.01 %. The quantitative content of the total amount of organic acids calculated with reference to malic acid in batches of Viburnum opulus fruits fluctuated more than 1.3 times from 6.80 ± 0.01 % to 9.08 ± 0.01 %.Conclusions. The quantitative content of the main groups of biologically active substances has been determined in 6 batches of Viburnum opulus fruits harvested in different regions of Ukraine using pharmacopoeial methods: polyphenols (varied by 1.4 times), tannins (varied by 1.7 times), the total amount of hydroxycinnamic (varied by 1.2 times), and the total amount of organic acids (varied by 1.3 times) calculated with reference to dried substance. The content of the groups of biologically active substances in batches of Viburnum opulus fruits slightly correlates with the place of the raw material harvesting. Thus, the selected methods of the SPhU 2.0 are quite suitable for determining the quantitative content of polyphenols, tannins and of the total amount of hydroxycinnamic and organic acids in batches of Viburnum opulus fruits; they can be used in further studies to standardize the raw material.
- Open Access
- 29 December 2021
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 6 (34),p. 51-57
Synthesis and antibacterial activity of 3-arylaminomethyl-1-(2-oxo-2-arylethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a] azepin-1-ium bromides and aryl-(4-R1-phenyl-5,6,7,8-tetrahydro-2,2a,8a-triazacyclopenta[cd]azulen-1-ylmethyl)-amines
The aim of this work is to develop methods of synthesis of 3-arylaminomethyl-1-(2-oxo-2-arylethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-1-ium bromides and aryl-(4-R1-phenyl-5,6,7,8-tetrahydro-2,2a,8a-triazacyclopenta[cd]azulen-1-ylmethyl)-amines and to study their antimicrobial activity against strains of gram-positive and gram-negative bacteria as well as yeast fungi. Materials and methods. 1Н NMR spectra were recorded on Bruker 400 spectrometer operating at frequency of 400 MHz. Antimicrobial activity of the compounds synthesized was evaluated by their minimum inhibitory concentration (MIC) values. Results and discussion. The interaction of 3-arylaminomethyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepines with substituted phenacyl bromides produced novel 3-arylaminomethyl-1-(2-oxo-2-arylethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-1-ium bromides. The latter when refluxed in 10 % solution of NaOH gave aryl-(4-R1-phenyl-5,6,7,8-tetrahydro-2,2a,8a-triazacyclopenta[cd]azulen-1-ylmethyl)-amines. The study of antimicrobial activity of the compounds obtained allowed to find derivatives which are active against С. albicans and S. aureus strains. Among the compounds tested 3-[(41-bromophenylamino)-methyl]-1-[2-(4-methoxyphenyl)-2-oxoethyl]-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-1-ium bromide 5cd appeared to be more active than the reference drug Cefixime and displayed close antimicrobial activity as the antibiotic Linezolid. Conclusions. It was found out that derivatives of 3-arylaminomethyl-1-(2-oxo-2-arylethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-1-ium bromides display broad spectrum of antimicrobial activity and are able to inhibit growth of both bacteria and fungi. S. aureus and C. albicans turned out to be the most sensitive strains to the compounds tested, MIC was in the range of 6.2-25.0 mg/mL. Gram-negative strains of microorganisms were less sensitive to the compounds evaluated and 5fа was the most active derivative displaying antimicrobial activity at the concentration of 50.0 mg/mL. Antimicrobial activity of triazoloazepinium bromide derivatives was similar to that one of Linezolid and Fluconazole reference drugs and more pronounced than the activity of Cefixime. Hence, the data gathered evidence the feasibility of further study of the antimicrobial properties of the most active compounds in in vivo experiments aiming at assessment of the prospects for the creation of new effective and safe antimicrobial drugs based on them
- 29 December 2021
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 6 (34),p. 51-57
Open AccessSynthesis and antibacterial activity of 3-arylaminomethyl-1-(2-oxo-2-arylethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a] azepin-1-ium bromides and aryl-(4-R1-phenyl-5,6,7,8-tetrahydro-2,2a,8a-triazacyclopenta[cd]azulen-1-ylmethyl)-amines
The aim of this work is to develop methods of synthesis of 3-arylaminomethyl-1-(2-oxo-2-arylethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-1-ium bromides and aryl-(4-R1-phenyl-5,6,7,8-tetrahydro-2,2a,8a-triazacyclopenta[cd]azulen-1-ylmethyl)-amines and to study their antimicrobial activity against strains of gram-positive and gram-negative bacteria as well as yeast fungi. Materials and methods. 1Н NMR spectra were recorded on Bruker 400 spectrometer operating at frequency of 400 MHz. Antimicrobial activity of the compounds synthesized was evaluated by their minimum inhibitory concentration (MIC) values. Results and discussion. The interaction of 3-arylaminomethyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepines with substituted phenacyl bromides produced novel 3-arylaminomethyl-1-(2-oxo-2-arylethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-1-ium bromides. The latter when refluxed in 10 % solution of NaOH gave aryl-(4-R1-phenyl-5,6,7,8-tetrahydro-2,2a,8a-triazacyclopenta[cd]azulen-1-ylmethyl)-amines. The study of antimicrobial activity of the compounds obtained allowed to find derivatives which are active against С. albicans and S. aureus strains. Among the compounds tested 3-[(41-bromophenylamino)-methyl]-1-[2-(4-methoxyphenyl)-2-oxoethyl]-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-1-ium bromide 5cd appeared to be more active than the reference drug Cefixime and displayed close antimicrobial activity as the antibiotic Linezolid. Conclusions. It was found out that derivatives of 3-arylaminomethyl-1-(2-oxo-2-arylethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-1-ium bromides display broad spectrum of antimicrobial activity and are able to inhibit growth of both bacteria and fungi. S. aureus and C. albicans turned out to be the most sensitive strains to the compounds tested, MIC was in the range of 6.2-25.0 mg/mL. Gram-negative strains of microorganisms were less sensitive to the compounds evaluated and 5fа was the most active derivative displaying antimicrobial activity at the concentration of 50.0 mg/mL. Antimicrobial activity of triazoloazepinium bromide derivatives was similar to that one of Linezolid and Fluconazole reference drugs and more pronounced than the activity of Cefixime. Hence, the data gathered evidence the feasibility of further study of the antimicrobial properties of the most active compounds in in vivo experiments aiming at assessment of the prospects for the creation of new effective and safe antimicrobial drugs based on them
- Open Access
- 23 December 2021
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 19 (4(76)) , 60-64
Selection of the optimal extractant for the extraction of phenolic compounds from Laurus nobilis L. leaves
Aim. To select the optimal extractant for the extraction of a number of groups of phenolic compounds from Lаurus nоbilis L. leaves based on the determination of the quantitative content of these groups in the extracts obtained. Materials and methods. Lаurus nоbilis L. leaves were harvested in November 2020 from artificially cultivated specimens aged 5 – 7 years. The quantitative determination of polyphenols was performed using the spectrophotometric method at a wavelength of 760 nm in accordance with the requirements of the Supplement of the State Pharmacopoeia of Ukraine (SPhU) 1.2 (2.8.14). The quantitative content of this group of compounds was calculated with reference to pyrogalol and dried substance. The quantitative determination of the amount of hydroxycinnamic acids was performed according to the SPhU 2.2 monograph “Orthosyphon stamen (kidney tea) leavesN” by the spectrophotometric method at a wavelength of 505 nm and calculated with reference to rosmarinic acid. The quantitative determination of the amount of flavonoids was performed according to the SPhU 2.0 monograph “Hawthorn leaves and flowers” by the spectrophotometric method at a wavelength of 410 nm and calculated with reference to hyperoside.Results and discussion. The analysis of the results for the quantitative determination of polyphenols, the amount of hydroxycinnamic acids and the amount of flavonoids in extracts from Lаurus nоbilis L. leaves obtained using water, water-ethanol mixtures and 96 % ethanol showed that 70 % ethanol was optimal for extracting compounds of these groups. The quantitative content of polyphenols (calculated with reference to pyrogalol) was not less than 21 %, the amount of hydroxycinnamic acids (calculated with reference to rosmarinic acid) – not less than 3 %, the amount of flavonoids (calculated with reference to hyperoside) – not less than 5 %. Conclusions. For the first time, the quantitative content of a number of groups of phenolic compounds (polyphenols, the total amount of hydroxycinnamic acids, and the total amount of flavonoids) in Lаurus nоbilis L. leaves extracts obtained using various extractants has been determined. On this basis, the optimal extractant – 70 % ethanol for the extraction of phenolic compounds has been selected. The results obtained will be used when developing the technology for obtaining substances from Lаurus nоbilis L. leaves.
- 23 December 2021
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 19 (4(76)) , 60-64
Open AccessSelection of the optimal extractant for the extraction of phenolic compounds from Laurus nobilis L. leaves
Aim. To select the optimal extractant for the extraction of a number of groups of phenolic compounds from Lаurus nоbilis L. leaves based on the determination of the quantitative content of these groups in the extracts obtained. Materials and methods. Lаurus nоbilis L. leaves were harvested in November 2020 from artificially cultivated specimens aged 5 – 7 years. The quantitative determination of polyphenols was performed using the spectrophotometric method at a wavelength of 760 nm in accordance with the requirements of the Supplement of the State Pharmacopoeia of Ukraine (SPhU) 1.2 (2.8.14). The quantitative content of this group of compounds was calculated with reference to pyrogalol and dried substance. The quantitative determination of the amount of hydroxycinnamic acids was performed according to the SPhU 2.2 monograph “Orthosyphon stamen (kidney tea) leavesN” by the spectrophotometric method at a wavelength of 505 nm and calculated with reference to rosmarinic acid. The quantitative determination of the amount of flavonoids was performed according to the SPhU 2.0 monograph “Hawthorn leaves and flowers” by the spectrophotometric method at a wavelength of 410 nm and calculated with reference to hyperoside.Results and discussion. The analysis of the results for the quantitative determination of polyphenols, the amount of hydroxycinnamic acids and the amount of flavonoids in extracts from Lаurus nоbilis L. leaves obtained using water, water-ethanol mixtures and 96 % ethanol showed that 70 % ethanol was optimal for extracting compounds of these groups. The quantitative content of polyphenols (calculated with reference to pyrogalol) was not less than 21 %, the amount of hydroxycinnamic acids (calculated with reference to rosmarinic acid) – not less than 3 %, the amount of flavonoids (calculated with reference to hyperoside) – not less than 5 %. Conclusions. For the first time, the quantitative content of a number of groups of phenolic compounds (polyphenols, the total amount of hydroxycinnamic acids, and the total amount of flavonoids) in Lаurus nоbilis L. leaves extracts obtained using various extractants has been determined. On this basis, the optimal extractant – 70 % ethanol for the extraction of phenolic compounds has been selected. The results obtained will be used when developing the technology for obtaining substances from Lаurus nоbilis L. leaves.
- Open Access
- 20 October 2021
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 19 (3(75)) , 47-52
The component composition of the essential oil from Laurus nobilis L. unripe fruits harvested in Ukraine
Aim. To study the qualitative composition and the quantitative content of the essential oil components from Laurus nobilis L. unripe fruits.Results and discussion. In the essential oil from Laurus nobilis L. unripe fruits 31 compounds were determined; among them 28 substances were identified. A high content was characteristic for spatulenol (1947.1 mg/kg) and betulenol (925.3 mg/kg).Experimental part. The raw material for obtaining the essential oil (unripe fruits) of Laurus nobilis L. was harvested in November 2017 in Alushta and the village of Rybalskoe, Crimea. The component composition of the essential oil of the unripe fruits from Laurus nobilis L. was studied and the constituents of the essential oil were identified by chromato-mass spectrometry using an Agilent Technology 6890N chromatograph. The component composition of the essential oil was revealed by comparing the results obtained with data from the NIST 02 mass spectrum library (more than 174.000 substances).Conclusions. The component composition of the essential oil from Laurus nobilis L. unripe fruits harvested in Ukraine has been studied. Taking into account the set of the biologically active compounds found in the essential oil of Laurus nobilis L. it can be argued that further pharmacognostic studies of fruits of this plant as the medicinal raw material with the predicted pharmacological activity (e.g., antimicrobial and skin cleansing) are promising.
- 20 October 2021
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 19 (3(75)) , 47-52
Open AccessThe component composition of the essential oil from Laurus nobilis L. unripe fruits harvested in Ukraine
Aim. To study the qualitative composition and the quantitative content of the essential oil components from Laurus nobilis L. unripe fruits.Results and discussion. In the essential oil from Laurus nobilis L. unripe fruits 31 compounds were determined; among them 28 substances were identified. A high content was characteristic for spatulenol (1947.1 mg/kg) and betulenol (925.3 mg/kg).Experimental part. The raw material for obtaining the essential oil (unripe fruits) of Laurus nobilis L. was harvested in November 2017 in Alushta and the village of Rybalskoe, Crimea. The component composition of the essential oil of the unripe fruits from Laurus nobilis L. was studied and the constituents of the essential oil were identified by chromato-mass spectrometry using an Agilent Technology 6890N chromatograph. The component composition of the essential oil was revealed by comparing the results obtained with data from the NIST 02 mass spectrum library (more than 174.000 substances).Conclusions. The component composition of the essential oil from Laurus nobilis L. unripe fruits harvested in Ukraine has been studied. Taking into account the set of the biologically active compounds found in the essential oil of Laurus nobilis L. it can be argued that further pharmacognostic studies of fruits of this plant as the medicinal raw material with the predicted pharmacological activity (e.g., antimicrobial and skin cleansing) are promising.
- Open Access
- 31 August 2021
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4(32),p. 50-58
Component composition of essential oil shoots and leaves of Laurus nobilis L. Ukrainian origian
The aim of our work was to carry out a comparative analysis of the essential oils of shoots and leaves of Laurus nobilis L. Ukrainian flora and to determine the prospects for their use in pharmacy. Materials and methods. Raw materials for obtaining essential oil (shoots and leaves) of Laurus nobilis L. were harvested in November 2017 in the southern regions of Ukraine. By the method of chromatography-mass spectrometry using an Agilent Technology 6890N chromatograph, the component composition of 4 samples of essential oil of Laurus nobilis L. raw material was investigated and identified. The composition of the essential oil was identified by comparing the results with the data from the NIsT 02 mass spectra library (more than 174,000 substances). Results. Thus, in the studied series of the essential oil of the shoots, a similarity was observed both in the set of components and in the relative content of a number of individual compounds and compounds of structurally related groups. The content in these samples was dominated by 1,8-cineole (19.63 % of the amount and 12.93 % of the amount, respectively), α-terpinyl acetate (16.22 % of the amount and 16.03 % of the amount, respectively). In contrast to the series of the essential oil of the shoots, the component composition of the essential oil of the leaves of the two series was significantly different. In both studied series, only 3 compounds were identified that are common - these are aromatic compounds methyleugenol, trans-methylisoevgenol, and the sequiterpenoid caryophyllene oxide. Conclusions. Thus, a comparative analysis of the component composition of biologically active substances in the essential oils of shoots and leaves of the Laurus nobilis L. Ukrainian harvest showed the prospects for further pharmacognostic research of this plant as a source of medicinal raw materials
- 31 August 2021
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4(32),p. 50-58
Open AccessComponent composition of essential oil shoots and leaves of Laurus nobilis L. Ukrainian origian
The aim of our work was to carry out a comparative analysis of the essential oils of shoots and leaves of Laurus nobilis L. Ukrainian flora and to determine the prospects for their use in pharmacy. Materials and methods. Raw materials for obtaining essential oil (shoots and leaves) of Laurus nobilis L. were harvested in November 2017 in the southern regions of Ukraine. By the method of chromatography-mass spectrometry using an Agilent Technology 6890N chromatograph, the component composition of 4 samples of essential oil of Laurus nobilis L. raw material was investigated and identified. The composition of the essential oil was identified by comparing the results with the data from the NIsT 02 mass spectra library (more than 174,000 substances). Results. Thus, in the studied series of the essential oil of the shoots, a similarity was observed both in the set of components and in the relative content of a number of individual compounds and compounds of structurally related groups. The content in these samples was dominated by 1,8-cineole (19.63 % of the amount and 12.93 % of the amount, respectively), α-terpinyl acetate (16.22 % of the amount and 16.03 % of the amount, respectively). In contrast to the series of the essential oil of the shoots, the component composition of the essential oil of the leaves of the two series was significantly different. In both studied series, only 3 compounds were identified that are common - these are aromatic compounds methyleugenol, trans-methylisoevgenol, and the sequiterpenoid caryophyllene oxide. Conclusions. Thus, a comparative analysis of the component composition of biologically active substances in the essential oils of shoots and leaves of the Laurus nobilis L. Ukrainian harvest showed the prospects for further pharmacognostic research of this plant as a source of medicinal raw materials
- Open Access
- 23 June 2021
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 19 (2(74)) , 36-43
The synthesis and antiviral activity against yellow fewer virus of 2-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides
Aim. To synthesize 2-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides and study their antiviral activity against yellow fever virus (YFV). Results and discussion. The target 2-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides were obtained in three-step format from cyanuric chloride in good to high yields. The carbothioamides synthesized were estimated to possess the antiviral activity against YFV. The results obtained indicate that most of the compounds studied show the inhibitory activity against YFV in concentrations ≤10 μg/mL. For the most active substances, EC90 was in the range of 0.06 – 2.2 μg/mL. Good effective concentration values were accompanied by low levels of cytotoxicity resulting in excellent selectivity index values. The data obtained also indicate that the presence of an alkyl substituent in ortho-position of the N-aryl fragment is crucial for an effective inhibition of YFV growth. Experimental part. 2-(4,6-Di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides were synthesized starting from cyanuric chloride in three steps by its successive interaction with two equivalents of pyrrolidine, hydrazine and a series of alkyl-/arylisothiocyanates. The antiviral and cytotoxic activities of the target carbothioamides were studied in the Southern Research Institute (SRI, Birmingham, Alabama) by the viral cytopathic effect reduction assay and the virus yield reduction assay. Conclusions. 2-(4,6-Di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides synthesized have been proven to be a promising class of compounds for treating such a severe viral disease as yellow fever.
- 23 June 2021
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 19 (2(74)) , 36-43
Open AccessThe synthesis and antiviral activity against yellow fewer virus of 2-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides
Aim. To synthesize 2-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides and study their antiviral activity against yellow fever virus (YFV). Results and discussion. The target 2-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides were obtained in three-step format from cyanuric chloride in good to high yields. The carbothioamides synthesized were estimated to possess the antiviral activity against YFV. The results obtained indicate that most of the compounds studied show the inhibitory activity against YFV in concentrations ≤10 μg/mL. For the most active substances, EC90 was in the range of 0.06 – 2.2 μg/mL. Good effective concentration values were accompanied by low levels of cytotoxicity resulting in excellent selectivity index values. The data obtained also indicate that the presence of an alkyl substituent in ortho-position of the N-aryl fragment is crucial for an effective inhibition of YFV growth. Experimental part. 2-(4,6-Di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides were synthesized starting from cyanuric chloride in three steps by its successive interaction with two equivalents of pyrrolidine, hydrazine and a series of alkyl-/arylisothiocyanates. The antiviral and cytotoxic activities of the target carbothioamides were studied in the Southern Research Institute (SRI, Birmingham, Alabama) by the viral cytopathic effect reduction assay and the virus yield reduction assay. Conclusions. 2-(4,6-Di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)-N-(alkyl, aryl)hydrazine-1-carbothioamides synthesized have been proven to be a promising class of compounds for treating such a severe viral disease as yellow fever.
- Open Access
- 22 February 2021
- Published by Pensoft Publishers in Pharmacia
- Vol. 68 (1) , 251-258
The synthesis and the antioxidant activity of 1-phenoxymethyl-4-aryl-5,6,7,8-tetrahydro-2a,4a,8a-triazacyclopenta[cd]azulene-3-carboxylic (or carbothionic) acid derivatives
New 1-phenoxymethyl-4-aryl-5,6,7,8-tetrahydro-2а,4a,8a-triazacyclopenta[cd]azulene-3-carboxylic (or carbothionic) acid derivatives have been designed, synthesized and evaluated for their in vitro antioxidant activity under conditions of the artificial oxidative stress using ionol, ascorbic acid and α-tocopherol as the reference drugs. It has been found that 1-phenoxymethyl-4-aryl-5,6,7,8-tetrahydro-2а,4a,8a-triazacyclopenta[cd]azulene-3-carbothionic acid derivatives 9b, 9c, 9d, 9e, 9f, 9i and 1-phenoxymethyl-4-(41-chlorophenyl)-5,6,7,8-tetrahydro-2,2a,8-triazacyclopenta[cd]azulene-3-carboxylic acid phenylamide 10 reveal a high antioxidant activity and a good in silico pharmacokinetic profile. The data obtained allowed us to select the most promising objects from the substances synthesized for further pharmacological screening for the presence of the antioxidant activity in vivo.
- 22 February 2021
- Published by Pensoft Publishers in Pharmacia
- Vol. 68 (1) , 251-258
Open AccessThe synthesis and the antioxidant activity of 1-phenoxymethyl-4-aryl-5,6,7,8-tetrahydro-2a,4a,8a-triazacyclopenta[cd]azulene-3-carboxylic (or carbothionic) acid derivatives
New 1-phenoxymethyl-4-aryl-5,6,7,8-tetrahydro-2а,4a,8a-triazacyclopenta[cd]azulene-3-carboxylic (or carbothionic) acid derivatives have been designed, synthesized and evaluated for their in vitro antioxidant activity under conditions of the artificial oxidative stress using ionol, ascorbic acid and α-tocopherol as the reference drugs. It has been found that 1-phenoxymethyl-4-aryl-5,6,7,8-tetrahydro-2а,4a,8a-triazacyclopenta[cd]azulene-3-carbothionic acid derivatives 9b, 9c, 9d, 9e, 9f, 9i and 1-phenoxymethyl-4-(41-chlorophenyl)-5,6,7,8-tetrahydro-2,2a,8-triazacyclopenta[cd]azulene-3-carboxylic acid phenylamide 10 reveal a high antioxidant activity and a good in silico pharmacokinetic profile. The data obtained allowed us to select the most promising objects from the substances synthesized for further pharmacological screening for the presence of the antioxidant activity in vivo.